Valuation : Psychemedics Corporation

Market Cap 9.79M 8.44M 7.99M 7.24M 13.58M 935M 13.65M 94.87M 36.48M 476M 36.77M 35.96M 1.5B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.22M 7.78M 7.05M 13.23M 911M 13.3M 92.44M 35.55M 464M 35.83M 35.04M 1.47B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
3 months+13.18%
6 months+71.72%
Current year+55.62%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
4.17
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 2023-08-16
Director of Finance/CFO 36 2023-11-26
Corporate Officer/Principal 40 2023-09-20
Director TitleAgeSince
Director/Board Member 64 2021-03-15
Director/Board Member 58 2022-04-03
Director/Board Member 64 2022-08-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
12/10/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
12/10/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+17.45%-36.96% 15.24M
+0.86%+0.23%+89.25%+502.55% 47.01B
+1.49%-4.70%+11.38%+54.28% 24.89B
-1.91%-2.76%-15.37%-38.61% 6.86B
+1.63%+2.41%+2.39%+156.68% 5.85B
-0.40%+1.68%+16.26%+71.90% 3.35B
+1.55%-0.84%-32.27%+1,687.53% 2.5B
-1.65%-0.35%+107.67%+24.69% 2.26B
+12.74%+4.41%+35.00%+45.74% 2.24B
-0.73%-2.96%-19.36%-56.60% 1.78B
Average +2.68%-0.03%+21.24%+241.12% 9.68B
Weighted average by Cap. +1.03%-1.22%+48.04%+311.61%

Financials

2023 2024
Net sales 22.1M 19.04M 18.03M 16.34M 30.66M 2.11B 30.81M 214M 82.34M 1.07B 82.99M 81.17M 3.39B 19.68M 16.96M 16.06M 14.56M 27.31M 1.88B 27.45M 191M 73.35M 957M 73.93M 72.31M 3.02B
Net income -4.15M -3.58M -3.39M -3.07M -5.76M -397M -5.79M -40.25M -15.48M -202M -15.6M -15.26M -638M -1.86M -1.6M -1.52M -1.38M -2.58M -178M -2.59M -18.03M -6.93M -90.45M -6.99M -6.84M -286M
Net Debt 334K 288K 272K 247K 463K 31.91M 466K 3.24M 1.24M 16.23M 1.25M 1.23M 51.3M -251K -216K -205K -186K -348K -23.98M -350K -2.43M -935K -12.2M -943K -922K -38.55M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!